Evidence map›Paper›PMID 35351541›Full record

ArticleThe Journal of infection2022

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment.

Jin Gu Yoon, Jin Sae Yoo, Jungmin Lee, Hak-Jun Hyun, Hye Seong, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim, Young Rong Kim, Jung Yeon Heo and 5 more

Abstract readLetter
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Jin Gu YoonDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
Jin Sae YooDepartment of Infectious Diseases, Ajou University School of Medicine, Suwon, South Korea.
Jungmin LeeDepartment of Microbiology, Biosafety Center, College of Medicine, Institute for Viral Diseases, Korea University, Seoul 02841, South Korea.
Hak-Jun HyunDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
Hye SeongDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
Ji Yun NohDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
Hee Jin CheongDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
Woo Joo KimDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
Young Rong KimDepartment of Infectious Diseases, Ajou University School of Medicine, Suwon, South Korea.
Jung Yeon HeoDepartment of Infectious Diseases, Ajou University School of Medicine, Suwon, South Korea.
Joon-Yong BaeDepartment of Microbiology, Biosafety Center, College of Medicine, Institute for Viral Diseases, Korea University, Seoul 02841, South Korea.
Chunguang CuiDepartment of Microbiology, Biosafety Center, College of Medicine, Institute for Viral Diseases, Korea University, Seoul 02841, South Korea.
Sohyun LeeDepartment of Microbiology, Biosafety Center, College of Medicine, Institute for Viral Diseases, Korea University, Seoul 02841, South Korea.
Man-Seong ParkDepartment of Microbiology, Biosafety Center, College of Medicine, Institute for Viral Diseases, Korea University, Seoul 02841, South Korea. Electronic address: ms0392@korea.ac.kr.
Joon Young SongDivision of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea. Electronic address: infection@korea.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentSARS-CoV-2Adenosine MonophosphateAlanineAntiviral AgentsDexamethasoneHumansAdenosine MonophosphateAlanineAntiviral AgentsDexamethasoneremdesivir

Identifiers

PMID35351541
PMCPMC8957381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.